Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and ...

Investors are clamoring to invest in publicly-traded cannabis companies as the legal marijuana market expands. Despite the clear growth potential in this industry, investors still need to exercise ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Cronos Group recently expanded its share repurchase program after the Toronto Stock Exchange approved its notice, allowing the company to buy back up to US$50,000,000 of common shares on both U.S. and ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Cronos Group (CRON Quick Quote CRON - Free Report) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.05 per share a year ago.

If you’re a true contrarian, you should look at cannabis stocks in 2023. A premier player in this abandoned stock sector is Cronos (NASDAQ:CRON). I believe that the severe multi-month beat down in ...

Cronos Group Inc (NASDAQ:CRON) reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report. Q1 Revenue: Cronos ...

Sales surged 38% year over year at the Canadian cannabis company, and Cronos noted that its "Spinach" brand of marijuana is now the No. 1 recreational cannabis brand in Canada. In medical marijuana, ...

Why does the DEA date matter for Cronos Group? At first glance, when the DEA holds its public meeting about rescheduling cannabis might not seem to matter to Cronos Group. The company doesn't sell ...